technetium tc 99m sestamibi has been researched along with Cancer, Second Primary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, A; Yang, B; Zhao, Q; Zuo, C | 1 |
| Celentano, L; Klain, M; Lastoria, S; Maurea, S; Salvatore, M | 1 |
| Casara, D; Pagetta, C; Pelizzo, MR; Rubello, D | 1 |
3 other study(ies) available for technetium tc 99m sestamibi and Cancer, Second Primary
| Article | Year |
|---|---|
99m Tc-MIBI SPECT/CT in a Case of Renal Oncocytosis.
Topics: Adenoma, Oxyphilic; Carcinoma, Renal Cell; Humans; Kidney; Kidney Neoplasms; Neoplasms, Second Primary; Single Photon Emission Computed Tomography Computed Tomography; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2023 |
Non-Hodgkin's lymphoma in a patient with follicular thyroid cancer: the role of 99mTc-methoxy isobutyl isonitrile imaging.
Topics: Adenocarcinoma, Follicular; Aged; Diagnosis, Differential; Female; Humans; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Neoplasms, Second Primary; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Thyroid Neoplasms | 1994 |
[Primary hyperparathyroidism in patients treated for non-medullary thyroid carcinoma].
Topics: Adenocarcinoma, Follicular; Adenoma; Adult; Carcinoma, Papillary; Combined Modality Therapy; Female; Humans; Hypercalcemia; Hyperparathyroidism; Iodine Radioisotopes; Middle Aged; Neoplasms, Second Primary; Parathyroid Neoplasms; Phosphorus; Postoperative Complications; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Technetium Tc 99m Sestamibi; Thyroid Neoplasms; Thyroidectomy | 2001 |